A Risk Sciences International news item posted on November 11, 2019 and last updated on November 11, 2019

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa and the Center for Alternatives to Animal Testing at Johns Hopkins University.

The meeting will be held at the University of Ottawa on December 5-6, 2019.  In addition to invited participants from Canada, the United States and Europe, the meeting is open to other interested participants on a space available basis.  Time has been allocated for poster presentations on December 5th, for participants who wish to present their own work in the area of evidence integration in risk assessment.

Individuals wishing to attend should contact Monique MacDonald mmacdonald@risksciences.com at Risk Sciences International expressing an interest in registering for the workshop.

Further information is available in the Preliminary Workshop Agenda.

A block of guest rooms has been arranged at Les Suites Hotel, 130 Besserer Street, Ottawa, until November 30, 2019. Reserve online at www.les-suites.com and select Preferred Group Rates (found under the All Rates heading).  Please use group code 217181 for your booking.

More RSI News

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…